AbbVie (NYSE: ABBV)
AbbVie Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
AbbVie Company Info
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
News & Analysis
2 Excellent Dividend Stocks to Buy on the Dip
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
3 Fantastic Stocks That Could Enjoy a Santa Claus Rally
2 Top Dividend Stocks to Buy and Hold Through 2025 and Beyond
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
These companies have ingrained competitive advantages in an evergreen industry backed by decades of dividend growth.
1 Magnificent S&P 500 Dividend Stock Down 14% to Buy and Hold Forever
Vanguard Value ETF (VTV): How to Buy
What Is the Fortune 100?
Valuation
Earnings Transcripts
AbbVie (ABBV) Q3 2024 Earnings Call Transcript
ABBV earnings call for the period ending September 30, 2024.
AbbVie (ABBV) Q2 2024 Earnings Call Transcript
ABBV earnings call for the period ending June 30, 2024.
AbbVie (ABBV) Q1 2024 Earnings Call Transcript
ABBV earnings call for the period ending March 31, 2024.
AbbVie (ABBV) Q4 2023 Earnings Call Transcript
ABBV earnings call for the period ending December 31, 2023.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.